Indication
Contrast-induced Acute Kidney Injury
1 clinical trial
1 product
Clinical trial
A Multicenter, Randomized, Open-label Phase II Clinical Trial Evaluating Alprostadil Liposomal Injection in the Prevention of Contrast-induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary InterventionStatus: Recruiting, Estimated PCD: 2024-02-01
Product
Alprostadil liposome